Evaluation of Preventive Effect of tofogliflozin on cardiovascular function in type 2 diabetes with cardiovascular diseases
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 17 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 30 Mar 2016 Status changed from not yet recruiting to recruiting.
- 04 Sep 2015 New trial record